Cytokinetics, Inc. (CYTK)

65.42 +0.05 (+0.08%) USD  |  NASDAQ  |  Apr 16, 16:00
65.55 +0.13 (+0.20%) Pre-Market: 08:47
More

Cytokinetics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for CYTK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Bristol Myers Squibb Co. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
AtriCure, Inc. Upgrade
Johnson & Johnson Upgrade
Corcept Therapeutics, Inc. Upgrade